Skip to content

High Intensity Interval Training in Chronic Heart Failure

The Effect of High-intensity Interval Training and Moderate Intensity Continuous Training on Cardiopulmonary Functions in Chronic Heart Failure

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05659420
Enrollment
60
Registered
2022-12-21
Start date
2023-01-01
Completion date
2025-12-31
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Rehabilitation, Chronic Heart Failure

Brief summary

The aim of this study is to investigate the effect of high-intensity interval training and moderate intensity continuous training on cardiopulmonary functions in chronic heart failure.

Detailed description

enroll chronic heart failure patients into 3 randomized controlled group * high intensity interval training * moderate intensity continous training * control perform cardica rehab for 12 weeks, compare primary and secondary endpoints between baseline and 12 weeks results

Interventions

BEHAVIORALCardiac rehabilitation comprised aerobic exercise on a treadmill accompanied by an electrocardiogram monitoring device and a blood pressure monitor

aerobic exercise on a treadmill (T7M, Motus, Paju, South Korea) accompanied by an electrocardiogram monitoring device (Q-Tel Rehabilitation Management System, Mortara Inc., Milwaukee, WI, USA) and a blood pressure monitor

Sponsors

Inha University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* medically stable chronic heart failure * NYHA II-III * can perform cardiopulmonary exercise test * after 3months with proper medication * age 30 to 70 * ejection fraction\< 40%

Exclusion criteria

* contraindication to cardiopulmonary exercise test * musculoskeletal problem who cannot perform cardiopulmonary exercise test * cognition deficit who cannot understand directions * severe medial illness

Design outcomes

Primary

MeasureTime frameDescription
Maximal or peak oxygen consumption (VO2max or VO2peak, same meaning) (kg/ml/min)compare baseline data with 12 weeks rehabilitation dataat the end of training, from baseline to 12 weeks

Secondary

MeasureTime frameDescription
6minute walk test (meter)compare baseline data with 12 weeks rehabilitation data
maximal heart rate (bpm)compare baseline data with 12 weeks rehabilitation data
systolic blood pressure (mmHg)compare baseline data with 12 weeks rehabilitation data
diastolic blood pressure (mmHg)compare baseline data with 12 weeks rehabilitation data
resting heart rate (bpm)compare baseline data with 12 weeks rehabilitation data
Anaerobic threshold (kg/ml/min)compare baseline data with 12 weeks rehabilitation dataThe anaerobic threshold is the highest exercise intensity that you can sustain for a prolonged period without lactate substantially building up in your blood.
depression scale by Patient Health Questionnairecompare baseline data with 12 weeks rehabilitation dataPatient Health Questionnaire (PHQ; range, 0-27; higher score = severe depression; cut-off score of 5 for minimal depression)
anxiety scale by Generalized Anxiety Disorder Scalecompare baseline data with 12 weeks rehabilitation dataGeneralized Anxiety Disorder Scale (GAD; range, 0-21; higher score = severe anxiety; cut-off score of 5 for mild anxiety)
fatigue scale by fatigue severity scalecompare baseline data with 12 weeks rehabilitation datafatigue severity scale (FSS; range, 9-63; higher score = severe fatigue; cut-off score of 4 for fatigue)
Quality of Life (QoL) questionnaire (MacNew)compare baseline data with 12 weeks rehabilitation dataMacNew QoL questionnaire is a measurement tool for patients with cardiac disease that measures physical, emotional, and social functional levels to provide overall QoL.
diastolic blood presure (mmHg)compare baseline data with 12 weeks rehabilitation data

Countries

South Korea

Contacts

Primary ContactKyung-Lim Joa, M.D.
drjoakl@gmail.com+82-10-9111-9432

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026